Human gene therapy - JoVE Visualize

Showing results (1101-1110 of 4,124) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|March 17, 2004

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccinesMiguel Aste-Amézaga, Andrew J Bett, Fubao Wang, et al.

Human Gene Therapy|August 21, 2004

Identification and characterization of novel human glioma-specific peptides to potentiate tumor-specific gene deliveryIvy A W Ho, Paula Y P Lam, Kam M Hui

Human Gene Therapy|August 21, 2004

Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitroRichard C Koya, Jeffrey S Weber, Nori Kasahara, et al.

Human Gene Therapy|August 21, 2004

Intraarterial delivery of naked plasmid DNA expressing full-length mouse dystrophin in the mdx mouse model of duchenne muscular dystrophyGoufeng Zhang, James J Ludtke, Christine Thioudellet, et al.

Human Gene Therapy|August 21, 2004

Adenovirus vector-mediated doxycycline-inducible RNA interferenceTetsuji Hosono, Hiroyuki Mizuguchi, Kazufumi Katayama, et al.

Human Gene Therapy|May 18, 2004

Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vectorIvy A W Ho, Kam M Hui, Paula Y P Lam

Human Gene Therapy|May 18, 2004

Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirusCarlos Manuel Corona Gutierrez, Alberto Tinoco, Tania Navarro, et al.

Human Gene Therapy|April 7, 2005

Good manufacturing practice production of adenoviral vectors for clinical trialsMonika Lusky

Human Gene Therapy|April 7, 2005

Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12Reinhard Waehler, Harald Ittrich, Lars Mueller, et al.

Human Gene Therapy|April 7, 2005

Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responsesChantal Feder-Mengus, Elke Schultz-Thater, Daniel Oertli, et al.

Pageof 413

Showing results (1101-1110 of 4,124) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|March 17, 2004

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccinesMiguel Aste-Amézaga, Andrew J Bett, Fubao Wang, et al.

Human Gene Therapy|August 21, 2004

Identification and characterization of novel human glioma-specific peptides to potentiate tumor-specific gene deliveryIvy A W Ho, Paula Y P Lam, Kam M Hui

Human Gene Therapy|August 21, 2004

Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitroRichard C Koya, Jeffrey S Weber, Nori Kasahara, et al.

Human Gene Therapy|August 21, 2004

Intraarterial delivery of naked plasmid DNA expressing full-length mouse dystrophin in the mdx mouse model of duchenne muscular dystrophyGoufeng Zhang, James J Ludtke, Christine Thioudellet, et al.

Human Gene Therapy|August 21, 2004

Adenovirus vector-mediated doxycycline-inducible RNA interferenceTetsuji Hosono, Hiroyuki Mizuguchi, Kazufumi Katayama, et al.

Human Gene Therapy|May 18, 2004

Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vectorIvy A W Ho, Kam M Hui, Paula Y P Lam

Human Gene Therapy|May 18, 2004

Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirusCarlos Manuel Corona Gutierrez, Alberto Tinoco, Tania Navarro, et al.

Human Gene Therapy|April 7, 2005

Good manufacturing practice production of adenoviral vectors for clinical trialsMonika Lusky

Human Gene Therapy|April 7, 2005

Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12Reinhard Waehler, Harald Ittrich, Lars Mueller, et al.

Human Gene Therapy|April 7, 2005

Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responsesChantal Feder-Mengus, Elke Schultz-Thater, Daniel Oertli, et al.

Pageof 413